Clinical Implication of Monitoring Interleukin-18 Receptor on Peripheral Lymphocytes for Diagnosis and Treatment of Rejection after Renal Transplantation

HAO Jun-wen,MIN Zhi-lian,LI Xiang-tie,CHEN Ying-jian,ZHENG Jun-hua
DOI: https://doi.org/10.3969/j.issn.1005-8982.2007.13.001
2007-01-01
Abstract:[Objective] To investigate the expression of interleukin-18 receptor (IL-18R) in renal transplantation recipients and to provide a quick, accurate and non-invasive diagnosis and selection of anti-rejection therapy for renal allograft rejection. [Methods] The expression of CD4/IL-l8Rα and CD8/IL-l8Rα on peripheral lymphocytes was determined by using flow cytometric analysis in uremia (n=32), renal transplantation recipients with stable function (n=24), with acute rejection (n=8), long-term survival (n=12) and healthy control (n=7). CD4/IL-l8Rα and CD8/IL-l8Rα expression was also determined before and after steroid pulse therapy to investigate the effects on the surface of the peripheral lymphocytes. [Results] CD4/IL-l8Rα and CD8/IL-l8Rα were (5.9±3.4)% and (14.9±4.6)% in healthy control respectively, and (17.6±9.7)% and (28.0±5.6)% in uremia patients respectively. Elevated serum levels of IL-l8Rα indicated poor prognosis after renal transplantation. IL-l8Rα expression was stronger after steroid pulse therapy in the 3 patients resistant to steroids than in the 5 patients responsive to steroid treatment. [Conclusions] Detection of CD4/IL-l8Rα and CD8/IL-l8Rα on the peripheral lymphocytes by flow cytometric analysis is an easy, hopeful, and noninvasive means for the diagnosis and treatment of patients with elevated create-nine after renal transplantation.
What problem does this paper attempt to address?